ArticleTherapeutic advances in musculoskeletal disease2020

Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study.

Wuu-Tsun Perng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.